NTRK1 and glioblastoma: In conclusion, we discovered a novel mechanism, whereby a non-tyrosine kinase decoy receptor (i.e., IL-13Rα2) is capable of regulating GBM tumorigenesis through the oncogenic signaling of a tyrosine kinase receptor (i.e., EGFRvIII).